HGG-03. INTEGRATED MOLECULAR AND PATHOLOGICAL CHARACTERISATION OF NON-BRAINSTEM PAEDIATRIC HIGH GRADE GLIOMA FROM THE HERBY PHASE II RANDOMISED TRIAL
Alan Mackay(Institute of Cancer Research), Chris Jones(North Carolina State University), Stefan M. Pfister(Heidelberg University), Josep Garcia(Roche (Switzerland)), Jacques Grill(Institut Gustave Roussy), Meghna Das Thakur(Gilead Sciences (United States)), Daniel Rodriguez Gutierrez(Nottingham University Hospitals NHS Trust), Gilles Vassal(Université Paris-Saclay), Tim Jaspan(Nottingham University Hospitals NHS Trust), Anna Burford(Cancer Research Institute of the Slovak Academy of Sciences), Pascale Varlet(Inserm), Paul S. Morgan(Nottingham University Hospitals NHS Trust), David Jones(German Cancer Research Center), Thomas Würdinger(Amsterdam University Medical Centers), Rachel Tam, Valeria Molinari(Institute of Cancer Research)
Cited by 1
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions
|The Journal of Experimental Medicine|2007|2.3k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k
The whole-genome landscape of medulloblastoma subtypes
|Nature|2017|1.2k